Ironwood Pharmaceuticals, Inc.
IRWDNASDAQHealthcareDrug Manufacturers - Specialty & Generic
As of Oct 15, 2026 close
- Market cap
- $630.26M
- P/E (TTM)
- 4.85
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $1.43$5.78
- Volume (live)
- -
- Avg. volume (3M)
- 2.01M
Ironwood Pharmaceuticals (IRWD) Stock Price & Financial Analysis
Ironwood Pharmaceuticals Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $3.63 - $3.87 |
|---|---|
| 52-Week High | $5.78 |
| 52-Week Low | $1.43 |
| Open | $3.63 |
| Volume (last close) | 2.04M |
| Average Volume (3M) | 2.01M |
| Revenue (TTM) | 389.32M |
|---|---|
| Net Income (TTM) | 129.87M |
| Free Cash Flow (TTM) | 185.55M |
| EPS (TTM) | $0.75 |
| Profit Margin | 33.36% |
| Operating Margin | 60.64% |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 630.26M |
|---|---|
| Shares Outstanding | 167.18M |
| P/E Ratio (TTM) | 4.85 |
| Price to Sales (P/S) | 1.62 |
| Price to Book (P/B) | -3.89 |
| EV/EBITDA | 3.95 |
| 50-Day MA | $4.12 |
|---|---|
| 200-Day MA | $4.02 |
| 1-Year Change | +143.23% |
Source: Market prices and company fundamentals. Data as of Oct 15, 2026. Data sources and methodology
Ironwood Pharmaceuticals at a Glance
As of the Oct 15, 2026 close, Ironwood Pharmaceuticals (IRWD) has a market capitalization of $630.26M. The stock trades at 4.8× trailing earnings and 1.6× sales. Over the trailing twelve months it earned $129.87M on revenue of $389.32M (a 33.4% profit margin) and generated $185.55M of free cash flow. Revenue grew 26.2% year over year.
As of its latest reported balance sheet, it holds $79.13M in cash and securities against $396.87M of debt, a net debt position of $317.74M.
Ironwood Pharmaceuticals does not currently pay a dividend.
The share price is up 143.2% over the past year. At $3.77 (the Oct 15, 2026 close) it sits within its 52-week range of $1.43 to $5.78, below its 200-day moving average of $4.02.
Based on 2 professional analyst ratings from the past 90 days, the consensus is Buy.
Frequently Asked Questions About Ironwood Pharmaceuticals
What is the current stock price for IRWD?
As of the Oct 15, 2026 close, IRWD stock trades at $3.77. The 52-week range is $1.43–$5.78, with a day range of $3.63–$3.87.
What is the P/E ratio for IRWD?
As of the Oct 15, 2026 close, Ironwood Pharmaceuticals's trailing twelve-month (TTM) P/E ratio is 4.8, meaning investors pay $4.8 for every $1 of annual earnings. Ironwood Pharmaceuticals operates in the Healthcare sector.
Does IRWD pay dividends?
Ironwood Pharmaceuticals does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.
What do analysts recommend for IRWD?
Based on ratings from 2 professional analysts over the last 90 days, the consensus for IRWD is Buy.
What is the market cap of IRWD?
As of the Oct 15, 2026 close, Ironwood Pharmaceuticals's market capitalization is $630.3M, classifying it as a small-cap company. Ironwood Pharmaceuticals operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.